Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma

Research output: Contribution to journal › Article › peer-review

28 Citations (Scopus)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{4013476edde74223bf890ee35bed1b19,

title = "Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma",

author = "Piers Patten",

year = "2022",

month = nov,

day = "22",

doi = "10.1182/bloodadvances.2022008150",

language = "English",

volume = "6",

journal = "Blood Advances",

issn = "2473-9529",

publisher = "American Society of Hematology",

number = "22",

}